Delivery Order SPE2DB25D3108-SPE2DB25FPCEX
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 120 tablets of 1.2 gram mesalamine delayed-release tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,286.56, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price delivery order type and an ultimate completion date of September 15, 2023. This contract is not designated as a set-aside procurement....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order for the supply of 180 tablets of Mesalamine 800 mg delayed-release tablets. The contract, valued at $7,879.55, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
The federal contract award is for the pharmaceutical product "MESALAMINE DR 1.2 GM TABLET 120S", awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $2,314.88 with a firm fixed price, and has an ultimate completion date of November 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,027.36, is for the delivery of 120 tablets of 1.2 gram Mesalamine delayed-release (DR) tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of March 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,258.34, is for the delivery of Mesalamine delayed-release tablets to support federal healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,559,898,250 tablets of Mesalamine delayed-release 1.2 gram tablets. The $2,902.92 Firm Fixed Price contract has a completion date of February 10, 2023 and was awarded on February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply Mesalamine delayed-release tablets to the U.S. government. The contract has a ceiling value of $1,858.33 and a period of performance through April 29, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued up...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,713,896 tablets of the medication Mesalamine DR 1.2 gram, with a ceiling value of $5,692.07. The contract is a firm fixed price delivery order with a period of performance extending to February 21, 2024. This award is part of a larger Indefinite...
This federal contract award is for the delivery of MESALAMINE 800 MG DR TABLET 180S to the Defense Logistics Agency (DLA). The $11,379.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 10, 2025. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $8,863.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,654,471 tablets of Mesalamine DR 1.2 GM, with a completion date of August 1, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...